Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2018

Feb 07, 2019

SELL
$59.1 - $93.26 $118,200 - $186,520
-2,000 Closed
0 $0
Q3 2018

Oct 19, 2018

BUY
$88.86 - $117.49 $88,860 - $117,490
1,000 Added 100.0%
2,000 $292,000
Q2 2018

Jul 25, 2018

SELL
$99.64 - $127.59 $99,640 - $127,590
-1,000 Reduced 50.0%
1,000 $157,000
Q1 2018

Apr 26, 2018

BUY
$105.8 - $150.94 $211,600 - $301,880
2,000 New
2,000 $342,000

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $485M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Dumont & Blake Investment Advisors LLC Portfolio

Follow Dumont & Blake Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dumont & Blake Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dumont & Blake Investment Advisors LLC with notifications on news.